疾病
机制(生物学)
表观遗传学
神经科学
生物
免疫失调
生物信息学
评论文章
发病机制
医学
生物医学
调解人
DNA甲基化
后生
计算生物学
免疫系统
病态的
药物开发
作者
Yanqun Luo,Ying Gao,Xiaoliang Deng,Lei Wang,Tao Wu
出处
期刊:MedComm
[Wiley]
日期:2025-11-16
卷期号:6 (12): e70482-e70482
被引量:9
摘要
Protein arginine methyltransferase 1 (PRMT1) serves as a critical epigenetic modulator involved in a wide range of physiological and pathological processes. Previous studies have established its fundamental roles in essential cellular mechanisms such as DNA repair, transcriptional regulation, and signal transduction. Dysregulation of PRMT1 has been further associated with the pathogenesis of various diseases, including cancer, metabolic disorders, and immune dysfunction. However, a systematic synthesis of the multifaceted functions of PRMT1 across these diverse pathological contexts remains lacking. This review seeks to address this gap by comprehensively examining the molecular mechanisms, biological functions, and context-dependent roles of PRMT1. We integrate recent advances spanning multiple disease domains, with a particular focus on cancer, chronic liver diseases, cardiovascular disorders, neurodegenerative conditions, and immune-related pathologies. In addition, we elucidate the mechanistic links between PRMT1 dysregulation and disease pathogenesis. Further, the development and clinical potential of small-molecule inhibitors are also summarized. This review offers new perspectives on PRMT1-related disease mechanisms and lays a theoretical foundation for the development of targeted therapies. Ultimately, this review aims to contribute to the progression of precision medicine and the enhancement of global health outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI